Overview
Rosario Martin-Sanchez practices practicing medicine in Granada, Spain.
Their clinical expertise encompasses Leishmaniasis, Triple-Negative Breast Cancer, and Breast Cancer.
They are actively involved in clinical research, co-authoring 36 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rosario M. Martin-Sanchez
Is Rosario M. Martin-Sanchez a top-rated expert for Leishmaniasis?
MediFind is an objective health platform that identifies experts based on real-world data. Rosario M. Martin-Sanchez is classified as an Experienced expert for Leishmaniasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rosario M. Martin-Sanchez participate in research or clinical trials?
Yes. Rosario M. Martin-Sanchez has published 36 articles and abstracts on conditions like Leishmaniasis. You can view a list of Rosario M. Martin-Sanchez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMartin-Sanchez isExperienced. Learn about Breast Cancer.
- LeishmaniasisMartin-Sanchez isExperienced. Learn about Leishmaniasis.
- Triple-Negative Breast CancerMartin-Sanchez isExperienced. Learn about Triple-Negative Breast Cancer.